358 related articles for article (PubMed ID: 12610649)
1. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
[TBL] [Abstract][Full Text] [Related]
4. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
6. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
7. The functional neuroanatomy of bipolar disorder.
Cerullo MA; Adler CM; Delbello MP; Strakowski SM
Int Rev Psychiatry; 2009; 21(4):314-22. PubMed ID: 20374146
[TBL] [Abstract][Full Text] [Related]
8. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder.
Thomas AJ; Davis S; Ferrier IN; Kalaria RN; O'Brien JT
Biol Psychiatry; 2004 Mar; 55(6):652-5. PubMed ID: 15013836
[TBL] [Abstract][Full Text] [Related]
9. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
Yasuno F; Suhara T; Okubo Y; Ichimiya T; Takano A; Sudo Y; Inoue M
Psychiatry Res; 2005 Apr; 138(3):197-207. PubMed ID: 15854788
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.
Karry R; Klein E; Ben Shachar D
Biol Psychiatry; 2004 Apr; 55(7):676-84. PubMed ID: 15038995
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
12. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G-protein signalling 4 expression is not altered in the prefrontal cortex in schizophrenia.
Stuart Gibbons A; Scarr E; McOmish CE; Hannan AJ; Thomas EA; Dean B
Aust N Z J Psychiatry; 2008 Aug; 42(8):740-5. PubMed ID: 18622782
[TBL] [Abstract][Full Text] [Related]
14. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
16. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression.
Regenold WT; Phatak P; Marano CM; Gearhart L; Viens CH; Hisley KC
Psychiatry Res; 2007 Jun; 151(3):179-88. PubMed ID: 17433451
[TBL] [Abstract][Full Text] [Related]
17. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
Digney A; Keriakous D; Scarr E; Thomas E; Dean B
Biol Psychiatry; 2005 Apr; 57(7):711-5. PubMed ID: 15820227
[TBL] [Abstract][Full Text] [Related]
18. Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder.
Bernstein HG; Dobrowolny H; Schott BH; Gorny X; Becker V; Steiner J; Seidenbecher CI; Bogerts B
J Psychiatr Res; 2013 Jun; 47(6):699-705. PubMed ID: 23462372
[TBL] [Abstract][Full Text] [Related]
19. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.
Thomas EA; Dean B; Pavey G; Sutcliffe JG
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4066-71. PubMed ID: 11274430
[TBL] [Abstract][Full Text] [Related]
20. Changes in gray matter volume in patients with bipolar disorder.
Adler CM; Levine AD; DelBello MP; Strakowski SM
Biol Psychiatry; 2005 Jul; 58(2):151-7. PubMed ID: 15922309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
